Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine - A multicenter, retrospective, observational study

BACKGROUND: After more than 2 years of the pandemic, effective treatment for COVID-19 is still under research. In recent months, publications hypothesized amantadine's potential beneficial effect on SARS-CoV-2 infection. OBJECTIVE: To compare the groups of Parkinson's Disease (PD) patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Przytuła, Filip, Kasprzak, Jakub, Dulski, Jarosław, Koziorowski, Dariusz, Kwaśniak-Butowska, Magdalena, Sołtan, Witold, Roszmann, Anna, Śmiłowska, Katarzyna, Schinwelski, Michał, Sławek, Jarosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724557/
https://www.ncbi.nlm.nih.gov/pubmed/36509028
http://dx.doi.org/10.1016/j.parkreldis.2022.105238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724557/
https://www.ncbi.nlm.nih.gov/pubmed/36509028
http://dx.doi.org/10.1016/j.parkreldis.2022.105238

Ejemplares similares